美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Parexel International Corporation

88.08

0.0000

成交量：- -

成交額：- -

市值：44.71億

市盈率：37.64

高：88.08

開：88.08

低：88.08

收：88.08

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Parexel International Corporation

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.parexel.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Parexel International Corporation 是一家領先的生物製藥服務公司，致力於臨床研究、醫療通訊、諮詢、商業化和先進的技術產品，以及為全球製藥、生物技術以及醫療器械等行業服務方面有着專業技術。Parexel的主要目標是提供高質量的解決方案管理生物製藥產品生命周期以減少時間、風險，以及新療法的開發和商業化。Parexel於1983年註冊成立， Parexel在支持其公司戰略流程和技術方面有着卓越的專業技術。 PAREXEL的產品和所提供的服務包括：臨床試驗管理，觀察性研究和病人/疾病登記，數據管理，生物統計分析，流行病學，衛生經濟學/結果研究，藥物警戒，醫學交流，臨床藥理學，患者招募，上市后監測，監管產品開發和商業化的諮詢，衛生政策和報銷諮詢，業績改善，醫療成像服務， ClinPhone隨機化和試驗供應管理服務（ RTSM ），電子數據採集系統（ EDC ），臨床試驗管理系統（ CTMS ），基於Web的門戶網站，系統集成，患者日記應用程序和其他產品開發服務。 PAREXEL於1983年註冊成立為一家監管事務諮詢公司，是一家馬薩諸塞州公司。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PRXL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRXL\",,,,,undefined,":{"symbol":"PRXL","market":"US","secType":"STK","nameCN":"Parexel International Corporation","latestPrice":88.08,"timestamp":1521662400000,"preClose":88.08,"halted":0,"volume":0,"delay":0,"floatShares":49903393,"shares":50762000,"eps":2.34,"marketStatus":"盤前交易","change":0,"latestTime":"05-19 07:22:45 EDT","open":88.08,"high":88.08,"low":88.08,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.34,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747661400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":816930000000,"exchange":"NASDAQ","adjPreClose":88.08,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRXL\",,,,,undefined,":{"symbol":"PRXL","floatShares":49903393,"roa":"--","roe":"--","lyrEps":0,"shares":50762000,"dividePrice":0,"high":88.08,"amplitude":0,"preClose":88.08,"low":88.08,"week52Low":51.16,"pbRate":"7.05","week52High":88.1,"institutionHeld":0.8988,"latestPrice":88.08,"eps":2.34,"divideRate":0,"volume":0,"delay":0,"ttmEps":2.34,"open":88.08,"prevYearClose":88.08},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.parexel.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0529},{"period":"1month","weight":0.1304},{"period":"3month","weight":-0.0254},{"period":"6month","weight":0.0144},{"period":"1year","weight":0.1239},{"period":"ytd","weight":0.0139}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Parexel International Corporation 是一家領先的生物製藥服務公司，致力於臨床研究、醫療通訊、諮詢、商業化和先進的技術產品，以及為全球製藥、生物技術以及醫療器械等行業服務方面有着專業技術。Parexel的主要目標是提供高質量的解決方案管理生物製藥產品生命周期以減少時間、風險，以及新療法的開發和商業化。Parexel於1983年註冊成立， Parexel在支持其公司戰略流程和技術方面有着卓越的專業技術。 PAREXEL的產品和所提供的服務包括：臨床試驗管理，觀察性研究和病人/疾病登記，數據管理，生物統計分析，流行病學，衛生經濟學/結果研究，藥物警戒，醫學交流，臨床藥理學，患者招募，上市后監測，監管產品開發和商業化的諮詢，衛生政策和報銷諮詢，業績改善，醫療成像服務， ClinPhone隨機化和試驗供應管理服務（ RTSM ） ，電子數據採集系統（ EDC ） ，臨床試驗管理系統（ CTMS ） ，基於Web的門戶網站，系統集成，患者日記應用程序和其他產品開發服務。 PAREXEL於1983年註冊成立為一家監管事務諮詢公司，是一家馬薩諸塞州公司。","exchange":"NASDAQ","name":"Parexel International Corporation","nameEN":"Parexel"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRXL\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRXL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-08-28","symbol":"PRXL","fiscalQuarterEnding":"2017/06","expectedEps":0.94,"name":null,"time":"盤後","type":"earning","dateTimestamp":1503892800000,"reportTimeType":"post","actualEps":1.02},{"market":"US","date":"2017-05-03","symbol":"PRXL","fiscalQuarterEnding":"2017/03","expectedEps":0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1493784000000,"reportTimeType":"post","actualEps":0.74},{"market":"US","date":"2017-02-01","symbol":"PRXL","fiscalQuarterEnding":"2016/12","expectedEps":0.83,"name":null,"time":"盤後","type":"earning","dateTimestamp":1485925200000,"reportTimeType":"post","actualEps":0.85},{"market":"US","date":"2016-10-26","symbol":"PRXL","fiscalQuarterEnding":"2016/09","expectedEps":0.86,"name":null,"time":"盤後","type":"earning","dateTimestamp":1477454400000,"reportTimeType":"post","actualEps":0.76},{"market":"US","date":"2016-08-03","symbol":"PRXL","fiscalQuarterEnding":"2016/06","expectedEps":0.92,"name":null,"time":"盤後","type":"earning","dateTimestamp":1470196800000,"reportTimeType":"post","actualEps":0.94}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRXL\",market:\"US\",delay:false,,,undefined,":{}}}